TARGETED INTEGRATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14899405

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure encompasses an isolated cell comprising an exogenous nucleic acid sequence located within or proximal to a predetermined genomic locus, wherein the exogenous nucleic acid sequence comprises at least one recognition sequence which can be exploited by one or more polynucleotide modification enzymes for targeted integration of a recombinant protein. The disclosure further provides methods for preparing such cells, and methods for retargeting such cells for the production of recombinant proteins, and kits for the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIGMA-ALDRICH CO LLC3050 SPRUCE STREET ST LOUIS MO 63103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BAHR, Scott St. Louis, US 3 4
BORGSCHULTE, Trissa St. Louis, US 5 4
KAYSER, Kevin St. Louis, US 8 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation